Supplement Maker Draws Warning Letter for GMP Violations, Misleading Promotion

Drug Industry Daily
A A
The FDA issued X2 Zero a warning letter, after investigators observed several GMP violations at the company’s Texas facility and unspecified active ingredients in its supplements.

To View This Article:

Login

Subscribe To Drug Industry Daily